These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 17583770)
1. Occurrence of pharmaceutically active and non-steroidal estrogenic compounds in three different wastewater recycling schemes in Australia. Al-Rifai JH; Gabelish CL; Schäfer AI Chemosphere; 2007 Oct; 69(5):803-15. PubMed ID: 17583770 [TBL] [Abstract][Full Text] [Related]
2. Analysis of pharmaceuticals in indirect potable reuse systems using solid-phase extraction and liquid chromatography-tandem mass spectrometry. Busetti F; Linge KL; Heitz A J Chromatogr A; 2009 Jul; 1216(31):5807-18. PubMed ID: 19560149 [TBL] [Abstract][Full Text] [Related]
3. Influence of residual organic macromolecules produced in biological wastewater treatment processes on removal of pharmaceuticals by NF/RO membranes. Kimura K; Iwase T; Kita S; Watanabe Y Water Res; 2009 Aug; 43(15):3751-8. PubMed ID: 19564034 [TBL] [Abstract][Full Text] [Related]
4. Removal of hormones and pharmaceuticals in the Advanced Water Recycling Demonstration Plant in Queensland, Australia. Khan SJ; Wintgens T; Sherman P; Zaricky J; Schäfer AI Water Sci Technol; 2004; 50(5):15-22. PubMed ID: 15497824 [TBL] [Abstract][Full Text] [Related]
5. Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant. Stackelberg PE; Furlong ET; Meyer MT; Zaugg SD; Henderson AK; Reissman DB Sci Total Environ; 2004 Aug; 329(1-3):99-113. PubMed ID: 15262161 [TBL] [Abstract][Full Text] [Related]
6. Determination and occurrence of organic micropollutants in reverse osmosis treatment for advanced water reuse. Gomez V; Majamaa K; Pocurull E; Borrull F Water Sci Technol; 2012; 66(1):61-71. PubMed ID: 22678201 [TBL] [Abstract][Full Text] [Related]
7. Occurrence and removal of pharmaceuticals, caffeine and DEET in wastewater treatment plants of Beijing, China. Sui Q; Huang J; Deng S; Yu G; Fan Q Water Res; 2010 Jan; 44(2):417-26. PubMed ID: 19674764 [TBL] [Abstract][Full Text] [Related]
8. Ozonation and biological activated carbon filtration of wastewater treatment plant effluents. Reungoat J; Escher BI; Macova M; Argaud FX; Gernjak W; Keller J Water Res; 2012 Mar; 46(3):863-72. PubMed ID: 22172561 [TBL] [Abstract][Full Text] [Related]
9. Removal of pharmaceuticals in secondary wastewater treatment processes in Taiwan. Lin AY; Yu TH; Lateef SK J Hazard Mater; 2009 Aug; 167(1-3):1163-9. PubMed ID: 19269086 [TBL] [Abstract][Full Text] [Related]
10. Occurrence of pharmaceutically active compounds during 1-year period in wastewaters from four wastewater treatment plants in Seville (Spain). Santos JL; Aparicio I; Callejón M; Alonso E J Hazard Mater; 2009 May; 164(2-3):1509-16. PubMed ID: 18990491 [TBL] [Abstract][Full Text] [Related]
11. Pharmaceuticals and pesticides in reclaimed water: Efficiency assessment of a microfiltration-reverse osmosis (MF-RO) pilot plant. Rodriguez-Mozaz S; Ricart M; Köck-Schulmeyer M; Guasch H; Bonnineau C; Proia L; de Alda ML; Sabater S; Barceló D J Hazard Mater; 2015 Jan; 282():165-73. PubMed ID: 25269743 [TBL] [Abstract][Full Text] [Related]
12. Fate and removal of pharmaceuticals and illicit drugs in conventional and membrane bioreactor wastewater treatment plants and by riverbank filtration. Petrovic M; de Alda MJ; Diaz-Cruz S; Postigo C; Radjenovic J; Gros M; Barcelo D Philos Trans A Math Phys Eng Sci; 2009 Oct; 367(1904):3979-4003. PubMed ID: 19736231 [TBL] [Abstract][Full Text] [Related]
13. Presence of pharmaceutically active compounds in Doñana Park (Spain) main watersheds. Camacho-Muñoz MD; Santos JL; Aparicio I; Alonso E J Hazard Mater; 2010 May; 177(1-3):1159-62. PubMed ID: 20122798 [TBL] [Abstract][Full Text] [Related]
14. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain). Santos JL; Aparicio I; Alonso E Environ Int; 2007 May; 33(4):596-601. PubMed ID: 17084895 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of advanced treatment technologies for the elimination of pharmaceutical compounds. Baumgarten S; Schröder HF; Charwath C; Lange M; Beier S; Pinnekamp J Water Sci Technol; 2007; 56(5):1-8. PubMed ID: 17881831 [TBL] [Abstract][Full Text] [Related]
16. Determination of acidic pharmaceuticals and potential endocrine disrupting compounds in wastewaters and spring waters by selective elution and analysis by gas chromatography-mass spectrometry. Gibson R; Becerril-Bravo E; Silva-Castro V; Jiménez B J Chromatogr A; 2007 Oct; 1169(1-2):31-9. PubMed ID: 17884063 [TBL] [Abstract][Full Text] [Related]
17. Endocrine-disrupting compounds: a review of their challenge to sustainable and safe water supply and water reuse. Falconer IR; Chapman HF; Moore MR; Ranmuthugala G Environ Toxicol; 2006 Apr; 21(2):181-91. PubMed ID: 16528694 [TBL] [Abstract][Full Text] [Related]
18. Screening health risk assessment of micropullutants for indirect potable reuse schemes: a three-tiered approach. Rodriguez C; Cook A; Van Buynder P; Devine B; Weinstein P Water Sci Technol; 2007; 56(11):35-42. PubMed ID: 18057639 [TBL] [Abstract][Full Text] [Related]
19. High performance RO membranes for desalination and wastewater reclamation and their operation results. Henmi M; Fusaoka Y; Tomioka H; Kurihara M Water Sci Technol; 2010; 62(9):2134-40. PubMed ID: 21045342 [TBL] [Abstract][Full Text] [Related]
20. Occurrence and removal of estrogens and beta blockers by various processes in wastewater treatment plants. Gabet-Giraud V; Miège C; Choubert JM; Ruel SM; Coquery M Sci Total Environ; 2010 Sep; 408(19):4257-69. PubMed ID: 20633734 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]